Can Breast Surgeons Provide Breast Cancer Genetic Testing? An American Society of Breast Surgeons Survey

被引:25
作者
Beitsch, Peter D. [1 ]
Whitworth, Pat W. [2 ]
机构
[1] Dallas Breast Ctr & Dallas Surg Grp, Dallas, TX 75230 USA
[2] Nashville Breast Ctr, Nashville, TN USA
关键词
TELEPHONE;
D O I
10.1245/s10434-014-3711-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Whether breast cancer surgeons are adequately trained, skilled, and experienced to provide breast cancer genetic assessment, testing, and counseling came under debate in September 2013 when a major third-party payer excluded nongenetics specialists from ordering such testing. A literature search having failed to uncover any study on breast surgeons' skill and practice in this area, the American Society of Breast Surgeons (ASBrS) surveyed its members on their experience with the recognized crucial components of such testing. In late 2013, ASBrS e-mailed a link to an online questionnaire to its U.S. members (n = 2,603) requesting a self-assessment of skills and experience in genetic assessment, testing, interpretation, and counseling. After approximately 6 weeks, the results were collated and evaluated. By January 2, 2014, 907 responses (34.84 %) had arrived from breast surgeons nationwide working in academic settings (20 %), solo or small group private practice (39 %), large multispecialty groups (18 %), and other settings. More than half said they performed 3-generation pedigrees, ordered genetic testing, and provided pre- and posttest counseling. Most noted that they would welcome continuing educational support in genetics. Currently the majority of breast surgeons provide genetic counseling and testing services to their patients. They report practices that meet or exceed recognized guidelines, including the necessary elements and processes for best practices in breast cancer genetics test counseling. Because breast cancer genetic testing is grossly underutilized relative to the size of the U.S. BRCA mutation carrier population, these appropriate services should not be restricted but rather supported and expanded.
引用
收藏
页码:4104 / 4108
页数:5
相关论文
共 15 条
[1]  
[Anonymous], 2011, SURG ASS HER CAUS BR
[2]  
[Anonymous], 2014, 15 ANN M AM SOC BREA
[3]  
[Anonymous], 2014, 24 INT BREAST CTR C
[4]   Who are we and what do we think? [J].
Beitsch, PD ;
Lerner, AG ;
Laidley, AL ;
Tafra, L ;
Edwards, MJ .
AMERICAN JOURNAL OF SURGERY, 2003, 186 (04) :321-323
[5]   Simplifying clinical use of the genetic risk prediction model BRCAPRO [J].
Biswas, Swati ;
Atienza, Philamer ;
Chipman, Jonathan ;
Hughes, Kevin ;
Barrera, Angelica M. Gutierrez ;
Amos, Christopher I. ;
Arun, Banu ;
Parmigiani, Giovanni .
BREAST CANCER RESEARCH AND TREATMENT, 2013, 139 (02) :571-579
[6]   Providing access to risk prediction tools via the HL7 XML-formatted risk web service [J].
Chipman, Jonathan ;
Drohan, Brian ;
Blackford, Amanda ;
Parmigiani, Giovanni ;
Hughes, Kevin ;
Bosinoff, Phil .
BREAST CANCER RESEARCH AND TREATMENT, 2013, 140 (01) :187-193
[7]  
Cho MK, 1999, AM J MED GENET, V83, P157, DOI 10.1002/(SICI)1096-8628(19990319)83:3<157::AID-AJMG4>3.0.CO
[8]  
2-G
[9]   Hereditary Breast and Ovarian Cancer and Other Hereditary Syndromes: Using Technology to Identify Carriers [J].
Drohan, Brian ;
Roche, Constance A. ;
Cusack, James C., Jr. ;
Hughes, Kevin S. .
ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (06) :1732-1737
[10]  
Genetic Evaluation and Management, 2013, 2013 BREAST CTR STAN